These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28220815)

  • 1. Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8
    Sun M; Ha N; Pham DH; Frederick M; Sharma B; Naruse C; Asano M; Pipkin ME; George RE; Thai TH
    Sci Rep; 2017 Feb; 7():42888. PubMed ID: 28220815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting
    Le PT; Ha N; Tran NK; Newman AG; Esselen KM; Dalrymple JL; Schmelz EM; Bhandoola A; Xue HH; Singh PB; Thai TH
    Front Immunol; 2021; 12():738958. PubMed ID: 34721405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD25-expressing Th17 cells mediate CD8
    Lang C; Wang J; Chen L
    Exp Cell Res; 2017 Nov; 360(2):384-389. PubMed ID: 28942020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2D
    Yang D; Tian Z; Zhang M; Yang W; Tang J; Wu Y; Ni B
    Sci Rep; 2017 Apr; 7(1):1288. PubMed ID: 28455530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.
    Zloza A; Kohlhapp FJ; Lyons GE; Schenkel JM; Moore TV; Lacek AT; O'Sullivan JA; Varanasi V; Williams JW; Jagoda MC; Bellavance EC; Marzo AL; Thomas PG; Zafirova B; Polić B; Al-Harthi L; Sperling AI; Guevara-Patiño JA
    Nat Med; 2012 Feb; 18(3):422-8. PubMed ID: 22366950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterochromatin protein 1 gamma reduces the number of primordial germ cells via impaired cell cycle progression in mice.
    Abe K; Naruse C; Kato T; Nishiuchi T; Saitou M; Asano M
    Biol Reprod; 2011 Nov; 85(5):1013-24. PubMed ID: 21778144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
    Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
    Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse correlation between NKG2D expression on CD8+ T cells and the frequency of CD4+CD25+ regulatory T cells in patients with esophageal cancer.
    Osaki T; Saito H; Fukumoto Y; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    Dis Esophagus; 2009; 22(1):49-54. PubMed ID: 18564160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity.
    Wang D; Quiros J; Mahuron K; Pai CC; Ranzani V; Young A; Silveria S; Harwin T; Abnousian A; Pagani M; Rosenblum MD; Van Gool F; Fong L; Bluestone JA; DuPage M
    Cell Rep; 2018 Jun; 23(11):3262-3274. PubMed ID: 29898397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The control of CD8+ T cell responses is preserved in perforin-deficient mice and released by depletion of CD4+CD25+ regulatory T cells.
    Ataera H; Simkins HM; Hyde E; Yang J; Hermans IF; Petersen TR; Ronchese F
    J Leukoc Biol; 2013 Oct; 94(4):825-33. PubMed ID: 23883515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsets.
    Rudd CE
    Eur J Immunol; 2009 Mar; 39(3):687-90. PubMed ID: 19283722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus.
    Zhan Y; Davey GM; Graham KL; Kiu H; Dudek NL; Kay T; Lew AM
    Immunol Cell Biol; 2009; 87(6):473-80. PubMed ID: 19381159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro induction of regulatory CD4+CD8α+ T cells by TGF-β, IL-7 and IFN-γ.
    Van Kaer L; Rabacal WA; Scott Algood HM; Parekh VV; Olivares-Villagómez D
    PLoS One; 2013; 8(7):e67821. PubMed ID: 23844100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
    Khan S; Burt DJ; Ralph C; Thistlethwaite FC; Hawkins RE; Elkord E
    Clin Immunol; 2011 Jan; 138(1):85-96. PubMed ID: 21056008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells.
    Goubier A; Vocanson M; Macari C; Poyet G; Herbelin A; Nicolas JF; Dubois B; Kaiserlian D
    J Invest Dermatol; 2013 Apr; 133(4):980-7. PubMed ID: 23190881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.